医薬品原薬 (API) の世界市場 (製造工程別、APIの種類別、医薬品の種類別、治療領域別)：産業分析、市場規模・シェア・成長・動向・予測
Active Pharmaceutical Ingredients (API) Market (Manufacturing Process; API Type; Drug Type; Therapeutic Area) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2023
|発行||Transparency Market Research||商品コード||328538|
|出版日||ページ情報||英文 115 Pages
|医薬品原薬 (API) の世界市場 (製造工程別、APIの種類別、医薬品の種類別、治療領域別)：産業分析、市場規模・シェア・成長・動向・予測 Active Pharmaceutical Ingredients (API) Market (Manufacturing Process; API Type; Drug Type; Therapeutic Area) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2023|
|出版日: 2018年04月13日||ページ情報: 英文 115 Pages||
当レポートでは、世界の医薬品原薬 (API) 市場について調査し、市場収益の実績・予測を提供しており、市場の促進因子・阻害因子の分析、製造手法・APIの種類・医薬品の種類・治療領域および地域別の分析と予測、競合情勢、主要企業のプロファイルなどをまとめ、お届けいたします。
Active Pharmaceutical Ingredients (API) Market
(Manufacturing Process - Captive and Contract; API Type - Synthetic Chemical and Biological; Drug Type - Branded, Generic, and OTC; Therapeutic Area - Cardiovascular, Metabolic, Neurological, Oncology, Musculoskeletal, and NSAIDs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2023.
Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. APIs of good quality are essential for the manufacture of effective and safe medicines. However, not all pharmaceutical companies possess in-house API manufacturing capabilities. Furthermore, a single company cannot produce all the APIs required for their formulation offerings.
The report provides detailed qualitative analysis of the market dynamics that affect the growth of the global market. Factors responsible for driving and restraining the growth of the global API market and future opportunities has been provided in the market overview section. This section of the report also provides comprehensive market comparative analysis and market attractiveness analysis for the global market by geography for the base year, Porter's Five Forces analysis, and market share analysis by key players (%) for the base year, operating in the active pharmaceutical ingredients market. The report also encompasses detailed event impact analysis and value chain analysis for the global market.
The global market has been broadly segmented on the basis of manufacturing process, type of API, types of drugs, therapeutic areas and geography. This report analyzes the current scenario as well as future market potential for market globally. This report comprises an elaborate executive summary, demonstrating a snapshot on market dynamics of various segments and sub-segments in a precise manner. Moreover, executive summary also comprises a waterfall chart, which reflects the market size of various segments in descending order.
The global API market is categorized in to captive manufacturing and contract manufacturing. Types of active pharmaceutical ingredients described in the global market include synthetic chemical API and biological API. Branded prescription drugs, generic prescription drugs, and over-the-counter drugs are various types of drugs covered in the global market. The global market encompasses various therapeutic areas such as cardiovascular disorders, oncology, metabolic disorders, neurological disorders, musculoskeletal disorders, NSAIDs and other therapeutic uses (such as infectious diseases). The market for these types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers.
Geographies discussed and analyzed in the global market include North America, Europe, Asia Pacific, and Rest of the World. In addition the report also comprises the precise and detailed country wise analysis for the global active pharmaceutical ingredients market such as North America (U.S. and Canada), Asia Pacific (China, Japan, India and Rest of Asia Pacific), and Europe (Germany, U.K. and Rest of Europe). The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2013 to 2023. The report on the market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2017 to 2023, considering 2016 as the base year.
A list of recommendations have been provided for new entrants to help establish a strong presence and for existing market players to take strategic decisions and to increase their market shares in the global active pharmaceutical ingredient market. The report concludes with the profiles of major players in the market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Allergan plc, BASF SE, Boehringer Ingelheim Group, Cambrex Corporation, Dr. Reddy's Laboratories Ltd., Lonza Group, Mylan, Inc., Sandoz (Novartis AG), Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and WuXi Apptec.
Key Segments of the Global Active Pharmaceutical Ingredients Market: